Recently, our group reported a significant increase in MMP9 transcripts, but not MMP2, in liver biopsies from obese NAFLD patients that underwent bariatric surgery as compared with samples from lean cholecystectomized patients. Here, MMP2 is linked to metabolic dysfunction-associated steatotic liver disease.